Researcher: Yot Teerawattananon, MD, PhD The ISPOR International Fellowship Award was established in 2006 to recognize key individuals who would contribute to the development of pharmacoeconomics and outcomes research or the use of outcomes research in health care decision in their own country/regio

นักวิจัย: Yot Teerawattananon, MD, PhD Dr. Yot Teerawattananon has received the ISPOR Best Contributed Podium Presentation Award on “Value of Information: An application in health economic evaluation of renal replacement therapy in Thailand” at ISPOR 2nd Asia-Pacific Conference, which was held in Sh

ISPOR 2008 International Fellowship Report: Is it Time to Think Seriously About Making HTA Available in Settings Where There is the Most Need? Yot Teerawattananon Health Intervention and Technology Assessment Program, Department of Health, Ministry of Public Health, Nonthaburi, Thailand Int

By Chayapat Rachatan and Kanchanok SirisonOn June 28, 2022, the Health Technology and Assessment Program (HITAP), Ministry of Public Health, Thailand, hosted a workshop on “Health incentive mechanisms present and future: UK’s experience of Pay for Performance and Quality Outcomes Framework (QOF)”. I

In Bhutan, respiratory infections are some of the major causes of morbidity and mortality in children. Pneumonia, an infection of the lungs, is among the top 10 common causes of children’s death in the country. Not only does it impose costs on society that may not be immediately visible (e.g. produ

In response to a lack of cost-effective data on screening and early treatment of diabetes and hypertension in resource-limited settings, a model-based economic evaluation was performed on the World Health Organization (WHO)’s Package of Essential Non-communicable (PEN) disease interventions for prim

At the recent Prince Mahidol Award Conference (PMAC) 2025, the Health Intervention and Technology Assessment Program (HITAP) Foundation hosted a side meeting on the role of artificial intelligence (AI) in healthcare. This meeting “Is AI a Panacea for the Health Sector? Navigating the Barriers to Ado

Is a HIV vaccine a viable option and at what price? An economic evaluation of adding HIV vaccination into existing prevention programs in Thailand Pattara Leelahavarong1*, Yot Teerawattananon1, Pitsaphun Werayingyong1, Chutima Akaleephan2, Nakorn Premsri3, Chawetsan Namwat3, Wiwat Peerapatanapoki

Involvement of consumers in health technology assessment activities by INAHTA agencies. David Haileya1, Sophie Werköa2, Rugayah Bakria3, Alun Camerona4, Britta Göhlena5, Susan Mylesa6, Jasmine Pwua7 and Jomkwan Yothasamuta8 For the INAHTA Working Group on Impact of HTA a1 University of Wollong

Indonesia established the HTA Committee (HTAC) for deciding the benefits package of the JKN, Indonesia’s universal health coverage (UHC) scheme, and since 2014 HITAP has worked closely with the HTAC to support the development of HTA in the country as part of the International Decision Support Initia